Bli medlem
Bli medlem

Du är här


AcuCort AB: AcuCort appoints Jonas Jönmark as new CEO

Jonas Jönmark has an MBA degree from Lund University, Sweden. He has more than 20 years' experience from leading positions as well as the CEO role in the pharmaceutical industry and the life science sector. His career has included big international pharma companies such as Pfizer AB, Astellas Pharma A/S and Astra Zeneca Sweden, but also smaller start-up companies such as Life Science Support AB and Alteco Medical AB.

Jonas has a broad experience from international product launches, establishment of sales- and distribution channels, commercial partnerships, pricing and reimbursement negotiations with authorities as well as international business development in life science. 

"I am very proud and humbled to be entrusted with the future development of AcuCort. I am looking forward to complete the market approval application for ISICORT®, the company's first product, and the possibility to lead a successful product launch on the market," says AcuCort's incoming CEO Jonas Jönmark.

"I am very pleased with the recruitment of Jonas Jönmark as CEO of AcuCort. Jonas has built a solid competence in the commercialization of pharmaceutical products and his experience matches very well with AcuCort's needs, given a possible market approval in Sweden of the company's drug candidate ISICORT®, says Ebba Fåhraeus, Chairman of the Board of AcuCort AB.

For further information, please contact
Ebba Fåhraeus, Chairman of the Board, AcuCort AB
Phone: +46 (0)73 400 04 33

This information is information that AcuCort AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person above, on July 16, 2020.


Författare AcuCort AB

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.